News: Health Reform WK-EDGE Wrap Up, LIFE SCIENCES TOP STORY—U.S.: BPCIA’s patent-dance rules clarified; notice allowed before FDA license received

June 14, 2017
...The Federal Circuit’s decision held that the information exchange is optional despite statutory language saying "shall provide," and that Amgen was entitled to an additional 180-day... In so holding, the Court determined that the Federal Circuit misinterpreted the statute, and clarified that Sec... The Court remanded the case to the Federal Circuit to determine whether California’s state unfair competition statute provides the injunctive remedy precluded by the BPCIA and if so, whether the BPCIA preempts state remedies...
padlock Available to subscribers

Would you like a free trial?

By entering email address, you agree to our privacy policy.